Wrong Use of Expedited Review Can Land IRBs a Warning — or Worse

Clinical Trials Advisor
A A
The expedited review process is intended to help IRBs quickly approve low-risk and noninvasive treatments during clinical trials.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00